Stock offerings often lead to dilution of existing shares, which can result in a decrease in stock price as the market absorbs the additional share supply. The filing by Aptose Biosciences for a significant number of shares and warrants indicates a potential dilution effect. Investors typically view such offerings as negative in the short term due to the dilutive effect and the potential for downward pressure on the stock price.